Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Bagel

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Drugs in Dermatology : JDD|March 5, 2015
Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibitionPaul S Yamauchi, Jerry Bagel
Cutis|June 6, 2022
Adjunctive Use of Halobetasol Propionate-Tazarotene in Biologic-Experienced Patients With PsoriasisJerry Bagel, Kristin Novak, Elise Nelson
Journal of Drugs in Dermatology : JDD|August 21, 2018
A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic TherapyJerry Bagel, James Zapata, Elise Nelson
Journal of Drugs in Dermatology : JDD|August 9, 2023
Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque PsoriasisJerry Bagel, Kristin Novak, Elise Nelson
The American Journal of the Medical Sciences|May 14, 2018
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to KnowSteven R Feldman, Jerry Bagel, Shahla Namak
Cutis|March 19, 2020
Halobetasol propionate for the management of psoriasisJerry Bagel, Quinn G Thibodeaux, George Han
Journal of the American Academy of Dermatology|April 29, 2005
Chordoma cutisAdam I Rubin, Jerry Bagel, George Niedt
Journal of Drugs in Dermatology : JDD|October 17, 2017
Apremilast and Narrowband Ultraviolet-B Combination Therapy for Treating Moderate-to-Severe Plaque PsoriasisJerry Bagel, Elise Nelson, Brian R Keegan
Cutis|March 16, 2026
Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque PsoriasisJerry Bagel, Alexa Hetzel, Ashley Reed, et al.
Dermatology and Therapy|October 13, 2020
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in PsoriasisJerry Bagel, Elise Nelson, James Zapata, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Drugs in Dermatology : JDD|March 5, 2015
Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibitionPaul S Yamauchi, Jerry Bagel
Cutis|June 6, 2022
Adjunctive Use of Halobetasol Propionate-Tazarotene in Biologic-Experienced Patients With PsoriasisJerry Bagel, Kristin Novak, Elise Nelson
Journal of Drugs in Dermatology : JDD|August 21, 2018
A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic TherapyJerry Bagel, James Zapata, Elise Nelson
Journal of Drugs in Dermatology : JDD|August 9, 2023
Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque PsoriasisJerry Bagel, Kristin Novak, Elise Nelson
The American Journal of the Medical Sciences|May 14, 2018
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to KnowSteven R Feldman, Jerry Bagel, Shahla Namak
Cutis|March 19, 2020
Halobetasol propionate for the management of psoriasisJerry Bagel, Quinn G Thibodeaux, George Han
Journal of the American Academy of Dermatology|April 29, 2005
Chordoma cutisAdam I Rubin, Jerry Bagel, George Niedt
Journal of Drugs in Dermatology : JDD|October 17, 2017
Apremilast and Narrowband Ultraviolet-B Combination Therapy for Treating Moderate-to-Severe Plaque PsoriasisJerry Bagel, Elise Nelson, Brian R Keegan
Cutis|March 16, 2026
Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque PsoriasisJerry Bagel, Alexa Hetzel, Ashley Reed, et al.
Dermatology and Therapy|October 13, 2020
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in PsoriasisJerry Bagel, Elise Nelson, James Zapata, et al.
Pageof 10